Please login to read the full text of the article.
If you have no account yet, please register now.
Posted on
Previous Article
« Thiopurine alone maintains remission in more than half of UC patients Next Article
Double-targeted CAR-T cell immunotherapy promising for refractory non-Hodgkin lymphoma »
« Thiopurine alone maintains remission in more than half of UC patients Next Article
Double-targeted CAR-T cell immunotherapy promising for refractory non-Hodgkin lymphoma »
Related Articles
April 5, 2021
‘Reassuring’ data on VTE risk in COVID-19 outpatients
March 5, 2020
Aspirin plus DOAC is not better than a DOAC alone
© 2021 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy